跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
里尔统 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Creatine Phosphate Sodium for Injection
Approved
化学药品
Creatine Phosphate Sodium for Injection
ADDENDA PHARMACEUTICALS S.R.L.
🇨🇳 National Medical Products Administration
Approval Date
Apr 23, 2020
Approval ID
7MazXbzfCYj
Company
ADDENDA PHARMACEUTICALS S.R.L.
Type
化学药品
Approval Details
Approval Id
7MazXbzfCYj
Approval Number
H20140265
Generic Name
注射用磷酸肌酸钠
Generic Name En
Creatine Phosphate Sodium for Injection
Trade Name
里尔统
Brand Name
里尔统
Drug Type
化学药品
Dosage Form
注射剂
Strength
1g
Reg Date
2020-04-23
Expired Date
2025-04-22
Company Name
ADDENDA PHARMACEUTICALS S.R.L.
Company Address
Strada Cluceru Udricani, Nr. 18, Etaj 4, Sector 3, Bucuresti, Romania
Production Company Name
ALFASIGMA SPA
Production Company Address
VIA ENRICO FERMI, 1-65020 ALANNO(PE)
Company Detail Path
/organization/addenda-pharmaceuticals-s-r-l
Production Company Detail Path
/organization/alfasigma-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 23, 2020
Approval ID
7MazXbzfCYj
Type
化学药品
Back to NMPA Approvals